新冠病毒检测与药物研发 |
|
|
|
|
新型冠状病毒抗原快速检测研发现状及展望* |
陈晨1,2,胡劲超1,2,曹姗姗1,2,门冬1,2,**() |
1 中国科学院武汉病毒研究所 生物安全大科学研究中心 病毒学国家重点实验室 武汉 430071 2 中国科学院大学 北京 100049 |
|
The Development of Antigen Testing for SARS-CoV-2 |
CHEN Chen1,2,HU Jin-chao1,2,CAO Shan-shan1,2,MEN Dong1,2,**() |
1 State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China 2 University of Chinese Academy of Sciences, Beijing 100049, China |
引用本文:
陈晨,胡劲超,曹姗姗,门冬. 新型冠状病毒抗原快速检测研发现状及展望*[J]. 中国生物工程杂志, 2021, 41(6): 119-128.
CHEN Chen,HU Jin-chao,CAO Shan-shan,MEN Dong. The Development of Antigen Testing for SARS-CoV-2. China Biotechnology, 2021, 41(6): 119-128.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2105056
或
https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I6/119
|
[1] |
Lancet T. Emerging understandings of 2019-nCoV. Lancet, 2020, 395(10221):311.
doi: S0140-6736(20)30186-0
pmid: 31986259
|
[2] |
Zhu N, Zhang D Y, Wang W L, et al. A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 2020, 382(8):727-733.
doi: 10.1056/NEJMoa2001017
pmid: 31978945
|
[3] |
Wang C, Horby P W, Hayden F G, et al. A novel coronavirus outbreak of global health concern. Lancet, 2020, 395(10223):470-473.
doi: 10.1016/S0140-6736(20)30185-9
|
[4] |
Tian H Y, Liu Y H, Li Y D, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science, 2020, 368(6491):638-642.
doi: 10.1126/science.abb6105
|
[5] |
朱民. 新冠肺炎疫情对全球经济和金融市场造成的冲击. 国际金融, 2020,(4):3-5.
|
|
Zhu M. Impact of Novel coronavirus pneumonia on global economic and financial markets. International Finance, 2020,(4):3-5.
|
[6] |
沈淑容, 马紫程, 许以灵, 等. 新型冠状病毒境外输入对我国疫情的影响. 浙江师范大学学报(自然科学版), 2021, 44(2):197-205.
|
|
Shen S R, Ma Z C, Xu Y L, et al. Epidemic impact of overseas-imported COVID-19 infected cases on China. Journal of Zhejiang Normal University (Natural Sciences), 2021, 44(2):197-205.
|
[7] |
Yesudhas D, Srivastava A, Gromiha M M. COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics. Infection, 2021, 49(2):199-213.
doi: 10.1007/s15010-020-01516-2
|
[8] |
Prather K A, Wang C C, Schooley R T. Reducing transmission of SARS-CoV-2. Science, 2020, 368(6498):1422-1424.
doi: 10.1126/science.abc6197
|
[9] |
Huang S Z, Jin Z, Peng Z H. Studies of the strategies for controlling the COVID-19 epidemic in China: Estimation of control efficacy and suggestions for policy makers. Scientia Sinica Mathematica, 2020, 50(6):885.
doi: 10.1360/SSM-2020-0043
|
[10] |
Niu Y, Xu F J. Deciphering the power of isolation in controlling COVID-19 outbreaks. The Lancet Global Health, 2020, 8(4):e452-e453.
doi: 10.1016/S2214-109X(20)30085-1
|
[11] |
Shen M W, Xiao Y N, Zhuang G H, et al. Mass testing-An underexplored strategy for COVID-19 control. The Innovation, 2021, 2(2):100114.
doi: 10.1016/j.xinn.2021.100114
|
[12] |
Kerr C C, Mistry D, Stuart R M, et al. Controlling COVID-19 via test-trace-quarantine. Nature Communications, 2021, 12:2993.
doi: 10.1038/s41467-021-23276-9
|
[13] |
Kim D, Lee J Y, Yang J S, et al. The architecture of SARS-CoV-2 transcriptome. Cell, 2020, 181(4): 914-921.e10.
doi: 10.1016/j.cell.2020.04.011
|
[14] |
Amanat F, Krammer F. SARS-CoV-2 vaccines: status report. Immunity, 2020, 52(4):583-589.
doi: 10.1016/j.immuni.2020.03.007
|
[15] |
Verdecchia P, Cavallini C, Spanevello A, et al. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine, 2020, 76:14-20.
doi: S0953-6205(20)30151-5
pmid: 32336612
|
[16] |
Azkur A K, Akdis M, Azkur D, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy, 2020, 75(7):1564-1581.
doi: 10.1111/all.v75.7
|
[17] |
Long Q X, Tang X J, Shi Q L, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Medicine, 2020, 26(8):1200-1204.
doi: 10.1038/s41591-020-0965-6
|
[18] |
Li Y J, Ji D P, Cai W Y, et al. Clinical characteristics, cause analysis and infectivity of COVID‐19 nucleic acid repositive patients: A literature review. Journal of Medical Virology, 2021, 93(3):1288-1295.
doi: 10.1002/jmv.v93.3
|
[19] |
Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the coronavirus disease 2019 (COVID-19), a comprehensive literature review. Diagnostic microbiology and infectious disease, 2020, 98(1):115094.
doi: S0732-8893(20)30471-5
pmid: 32623267
|
[20] |
Arthur Ricardo Vilar Scavuzzi de Carvalho, Cezarotti Filho M L, Azevedo P C P D, et al. Epidemiology, diagnosis, treatment, and future perspectives concerning SARS-CoV-2: a review article. Revista Da Associacao Medica Brasileira (1992), 2020, 66(3):370-374.
doi: S0104-42302020000300370
pmid: 32520160
|
[21] |
Yan Y, Chang L, Wang L N. Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures. Reviews in Medical Virology, 2020, 30(3):e2106.
|
[22] |
Ravi N, Cortade D L, Ng E, et al. Diagnostics for SARS-CoV-2 detection: a comprehensive review of the FDA-EUA COVID-19 testing landscape. Biosensors & Bioelectronics, 2020, 165:112454.
doi: 10.1016/j.bios.2020.112454
|
[23] |
Zhang J, Ding N, Song Y Z, et al. Phylogenomic tracing of asymptomatic transmission in a COVID-19 outbreak. The Innovation, 2021, 2(2):100099.
doi: 10.1016/j.xinn.2021.100099
|
[24] |
Jung J, Garnett E, Jariwala P, et al. Clinical performance of a semi-quantitative assay for SARS-CoV-2 IgG and SARS-CoV2 IgM antibodies. Clinica Chimica Acta, 2020, 510:790-795.
doi: 10.1016/j.cca.2020.09.023
|
[25] |
Ayouba A, Thaurignac G, Morquin D, et al. Multiplex detection and dynamics of IgG antibodies to SARS-CoV-2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV. Journal of Clinical Virology, 2020, 129:104521.
doi: 10.1016/j.jcv.2020.104521
|
[26] |
La Marca A, Capuzzo M, Paglia T, et al. Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays. Reproductive Biomedicine Online, 2020, 41(3):483-499.
doi: 10.1016/j.rbmo.2020.06.001
|
[27] |
World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays: interim guidance-11 September 2020. Geneva: World Health Organization, 2020.
|
[28] |
Mina M J, Peto T E, García-Fiñana M, et al. Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19. The Lancet, 2021, 397(10283):1425-1427.
doi: 10.1016/S0140-6736(21)00425-6
|
[29] |
Bahadir E B, Sezgintürk M K. Lateral flow assays: Principles, designs and labels. TrAC Trends in Analytical Chemistry, 2016, 82:286-306.
doi: 10.1016/j.trac.2016.06.006
|
[30] |
Oran D P, Topol E J. The proportion of SARS-CoV-2 infections that are asymptomatic. Annals of Internal Medicine, 2021, 174(5):655-662
doi: 10.7326/M20-6976
|
[31] |
Simon V, van Bakel H, Sordillo E M. Positive, again! What to make of “re-positive” SARS-CoV-2 molecular test results. EBioMedicine, 2020, 60:103011.
doi: 10.1016/j.ebiom.2020.103011
|
[32] |
罗银波, 吴杨, 刘漫, 等. 常态化新冠肺炎防控策略与机制的思考. 公共卫生与预防医学, 2020, 31(6):1-5.
|
|
Luo Y B, Wu Y, Liu M, et al. Thoughts on the strategy and mechanism for the regular prevention and control of COVID-19. Journal of Public Health and Preventive Medicine, 2020, 31(6):1-5.
|
[33] |
Ghoshal S, Mitra D, Roy S, et al. Biosensors and biochips for nanomedical applications: a review. Sensors & Transducers, 2010, 113(2):1.
|
[34] |
Vo-Dinh T, Cullum B. Biosensors and biochips: advances in biological and medical diagnostics. Fresenius’ Journal of Analytical Chemistry, 2000, 366(6-7):540-551.
doi: 10.1007/s002160051549
|
[35] |
Slomovic S, Pardee K, Collins J J. Synthetic biology devices for in vitro and in vivo diagnostics. Proceedings of the National Academy of Sciences of the United States of America, 2015, 112(47):14429-14435.
|
[36] |
Sposito A J, Kurdekar A, Zhao J Q, et al. Application of nanotechnology in biosensors for enhancing pathogen detection. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 2018, 10(5):e1512. DOI: 10.1002/wnan.1512.
|
[37] |
Myers F B, Lee L P. Innovations in optical microfluidic technologies for point-of-care diagnostics. Lab on a Chip, 2008, 8(12):2015-2031.
doi: 10.1039/b812343h
|
[38] |
Livingston A D, Campbell C J, Wagner E K, et al. Biochip sensors for the rapid and sensitive detection of viral disease. Genome Biology, 2005, 6(6):112.
pmid: 15960809
|
[39] |
von Bomhard A, Elsässer A, Ritschl L M, et al. Cryopreservation of endothelial cells in various cryoprotective agents and media - vitrification versus slow freezing methods. PLoS One, 2016, 11(2):e0149660.
doi: 10.1371/journal.pone.0149660
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|